suck pdf from google scholar
unlimited free pdf from europmc20558828    free
PDF from PMC    free
html from PMC    free
PDF vom PMID20558828  :  Publisher
PDF vom PMID20558828
suck pdf from library genesis
English Wikipedia

Nephropedia Template TP (

Twit Text


  • DeepDyve
  • Pubget Overpricing


  • lüll
  • Role of the urokinase plasminogen activator receptor in mediating impaired efferocytosis of anti-SSA/Ro-bound apoptotic cardiocytes: Implications in the pathogenesis of congenital heart block
  • Briassouli P; Komissarova EV; Clancy RM; Buyon JP
  • Circ Res 2010[Aug]; 107 (3): 374-87
  • RATIONALE: Binding of maternal anti-Ro/La antibodies to cognate antigen expressed on apoptotic cardiocytes decreases clearance by healthy cardiocytes, which may contribute to the development of autoimmune associated congenital heart block and fatal cardiomyopathy. OBJECTIVE: Given recent evidence implicating the urokinase plasminogen activator receptor (uPAR) as a "don't eat me" signal during efferocytosis, experiments addressed whether surface bound anti-Ro antibodies inhibit apoptotic cell removal via an effect on the expression/function of the urokinase-type plasminogen activator protease uPA/uPAR system. METHODS AND RESULTS: As assessed by flow cytometry and confocal microscopy, uPAR colocalizes and interacts with Ro60 on the surface of apoptotic human fetal cardiocytes. Blocking of uPAR enhances phagocytosis of apoptotic cardiocytes by healthy cardiocytes and reverses the anti-Ro60-dependent impaired clearance of apoptotic cardiocytes. Binding of anti-Ro60 antibodies to apoptotic cardiocytes results in increased uPAR expression, as well as enhanced uPA activity. The binding of anti-Ro60 did not alter other surface molecules involved in cell recognition (calreticulin, CD31, or CD47). CONCLUSIONS: These data suggest that increased uPAR expression and uPA activity induced by anti-Ro60 binding to the apoptotic fetal cardiocyte provide a molecular basis by which these antibodies inhibit efferocytosis and ultimately lead to scar of the fetal conduction system and working myocardium.
  • |Animals[MESH]
  • |Antibodies, Monoclonal[MESH]
  • |Apoptosis[MESH]
  • |CD47 Antigen/metabolism[MESH]
  • |Calreticulin/metabolism[MESH]
  • |Cardiomyopathies/immunology[MESH]
  • |Chickens/immunology[MESH]
  • |Female[MESH]
  • |Fetal Diseases/genetics[MESH]
  • |Fetus/physiology[MESH]
  • |Flow Cytometry[MESH]
  • |Heart Block/*congenital/etiology/genetics[MESH]
  • |Heart Conduction System/pathology[MESH]
  • |Humans[MESH]
  • |Immunoglobulin G[MESH]
  • |Mice[MESH]
  • |Microscopy, Confocal[MESH]
  • |Myocytes, Cardiac/immunology/pathology/physiology[MESH]
  • |Platelet Endothelial Cell Adhesion Molecule-1/metabolism[MESH]
  • |Pregnancy[MESH]
  • |Receptors, Urokinase Plasminogen Activator/antagonists & inhibitors/*genetics[MESH]
  • |Urokinase-Type Plasminogen Activator/metabolism[MESH]





  • *{{pmid20558828}}
    *<b>[http://www.kidney.de/mlpefetch.php?search=20558828 Role of the urokinase plasminogen activator receptor in mediating impaired efferocytosis of anti-SSA/Ro-bound apoptotic cardiocytes: Implications in the pathogenesis of congenital heart block ]</b> Circ Res 2010; 107(3) ; 374-87 Briassouli P; Komissarova EV; Clancy RM; Buyon JP

        *20558828*

    Nephropedia PMID record

    Deutsche Wikipedia - im Artikel

    Hier den unten stehenden Textblock hineinkopieren

    Circ Res

    374 3.107 2010